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Objective: This study aims to assess the nutritional status of selenium, copper and zinc; and
also  the erythrocyte superoxide dismutase activity of HIV-infected children compared to a
control group.
Methods: A cross-sectional study was carried out with prepubertal HIV-infected children
(n  = 51) and their healthy siblings (n = 32). All biochemical measurements including plasma
selenium, serum copper levels, serum and erythrocyte zinc levels and erythrocyte super-
oxide  dismutase activity were evaluated according to dietary, clinical and biochemical
parameters.
Results:  Compared to the control group, the HIV-infected children had lower z-score val-
ues  for height-for-age (p = 0.0006), higher prevalence of stunting (11.8%) (p = 0.047), lower
selenium  levels (p = 0.0006) and higher copper levels (p = 0.019). No difference was found con-
cerning  superoxide dismutase activity (p > 0.05). The HIV-infected group presented a higher
proportion  (45.1%) of children with zinc intakes below the estimated average requirement
(p  = 0.014); however, no association with zinc biochemical parameters was found.
Conclusion:  HIV-infected children have an inadequate selenium and copper nutritional sta-
tus, which could inﬂuence the progression to AIDS. An adequate micronutrient status couldconditions in these patients and minimize free radical production andimprove the clinical cellular  oxidative stress.
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serum  zinc in females. SOD activity in erythrocytes was
measured by spectrophotometry and adequate values range
from  4.7 to 5.7 U/mg of hemoglobin (Hb).19482  b r a z j i n f e c t d 
Introduction
Oxidative stress, which is caused by an increased production
of  free radicals and/or an inadequate antioxidant protection
mechanism, can be worsened by HIV infection, thereby com-
promising  the immune system.1,2
Antioxidants protect cells and tissues against inﬂamma-
tory and infectious processes and inhibit lipid peroxidation,
acting as anti-atherogenic agents.3 Selenium and copper may
inﬂuence  the progression from HIV to AIDS.4,5 Zinc and cop-
per  are components of superoxide dismutase (CuZnSOD),
an  important antioxidant enzyme; therefore, deﬁciencies
in  these minerals may  affect this enzyme activity.6 Inade-
quate  intake of antioxidants, such as vitamins and minerals,
can  lead to impaired immune system and increase in lipid
peroxidation, predisposing the individual to infections and
aggravating  the malnutrition problem.3
In addition to antioxidant nutrients, antioxidant enzymes
(e.g.,  superoxide dismutase, catalase, and glutathione per-
oxidase)  play crucial roles in eliminating free radicals and
minimizing the effects of cellular oxidative stress.7
HIV infection itself and its treatment can determine
metabolic changes that may  increase the mortality risk for
HIV-infected  children. Nutritional status and biochemical
parameters should be evaluated in HIV-infected individuals
with  low intakes of antioxidant nutrients to minimize adverse
health  effects.
The  objectives of this study were to assess the trace
elements antioxidant nutritional status and to determine
the  erythrocyte superoxide dismutase (SOD) activity in pre-
pubertal  HIV-infected individuals compared to the control
group.
Materials/subjects  and  methods
Subjects
A cross-sectional study, which included 83 prepubertal chil-
dren  from both sex, followed up at the Care Center of
the  Division of Pediatric Infectious Diseases, Department of
Pediatrics  (CEADIPe), Universidade Federal de São Paulo –
UNIFESP/EPM,  São Paulo, Brazil. Data were  collected from
October  2009 to October 2011. This study was  approved by
the  Ethics Committee of Universidade Federal de São Paulo
–  UNIFESP/EPM and written informed consent was  obtained
from  all of the subjects.
Subjects  were  distributed into two groups:
I. The HIV-infected group consisted of 51 children to whom
HIV  was  transmitted vertically.
II.  The control group consisted of 32 healthy siblings who
were  born before the diagnosis of HIV infection in the
mother. Mothers were  not infected yet with HIV by the time
of  their pregnancy and/or delivery and it was conﬁrmed by
laboratory  tests.Only  children who had a Tanner stage 1 pubertal
development8 were  enrolled in the study. Children with 1 4;1  8(5):481–486
other  chronic diseases that could interfere with micronu-
trient nutritional status or who were  receiving vitamin or
mineral  supplement and also those that were  hospitalized
or  presented severe clinical complications in the year before
entering  the study were not included.
Clinical  and  immunological  assessment
HIV infection was classiﬁed according to the clinical and
immunological parameters described by the CDC guidelines
(1994).9 Plasma HIV-1 RNA (viral load) was  measured by poly-
merase  chain reaction using the Amplicor HIV-1 Monitor
(Amplicor Roche Diagnostics), which has a detection limit of
400  copies/mL; values were expressed as log10. The CD4+ cell
count  was  determined by ﬂow cytometry and was  expressed
as  percentage (%).9
Anthropometry  assessment  and  dietary  intake
Weight (kg) and height (cm) measurements were  used to cal-
culate  height-for-age (H/A) z-score and body mass index (BMI)
z-score,  according to WHO  Child Growth Standards (2007).10
Energy and macro and micronutrient intake were  obtained
from  the average of four 24-h dietary recalls.11 Data were
analyzed using DietWin® software – Porto Alegre, Rio Grande
do  Sul, Brazil. Estimated energy requirement (EER) equations
were  used to assess the daily dietary energy requirements.
For the macronutrients, we used the acceptable macronutri-
ent  distribution range (AMDRs) and the intake was expressed
as  a percentage of the total energy value (TE).12 The estimated
average requirement (EAR) was used for the micronutrients
evaluation, values below the cut-off points indicated inade-
quate  nutrient intake.13
Laboratory  analyses
Biochemical parameters were measured in the absence of
infectious  processes. Following a 12-h fast, 10 mL  of blood was
collected  by venipuncture.
Plasma  selenium levels were  determined by hydride gener-
ation  atomic absorption spectrometry (HITACHI brand, model
Z-5000)  coupled to a quartz cell (HGQTAAS).14 Values were
considered low or high when they were below the 2.5 per-
centile  or above the 9.7 percentile, respectively, for age and
gender.15 Serum copper measurement were  analyzed by
atomic  absorption spectrophotometry (PERKIN ELMER brand,
model  5.100).16 The reference values used were  70–140 g/dL
for  males and 80–155 g/dL for females.17 Serum and erythro-
cyte  zinc concentrations were analyzed by atomic absorption
spectrophotometry (PERKIN ELMER brand, model 5.100).16 The
reference  values are 40–44 g Zn/g Hb for erythrocyte zinc,18
65–120 g/dL for serum zinc in males, and 60–120 g/dL for
17The Advia Chemistry System 1650 (Bayer®) analyzer and
a  turbidimetric assay were  used to evaluate the level of C-
reactive  protein (CRP) in the subjects.
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Table 1 – Anthropometric characteristics, nutritional status, and virological and immunological assessment of
HIV-infected (n = 51) and control (n = 32) groups.
HIV-infected Control  p value
Age (years)a,b 8.3 (7.4–9.4) 9.1 (8.4–9.7) 0.0110b
Malec,d 31 (60.8) 18 (56.2) 0.6830
BMIc (kg/m2)a,b 15.5 (14.7–16.6) 16.2 (14.9–17.6) 0.1536
BMI  z-scoreb,e,f −0.18 (−0.91 to 0.39) −0.08 (−0.76 to 0.54) 0.4402
Height for age z-scoreb,f −1.05 (−1.55 to −0.23) −0.24 (−0.80 to 0.72) 0.0006
Nutritional statusf
Stuntingf,g 6 (11.8) 0 (0) 0.0470
Eutrophicf,g 45 (88.2) 28 (87.5) 0.4280
Overweight + obesityf 4 (7.8) 4 (12.5)
Undernutritionf 2 (3.9) 0 (0)
Immunological parameters
Viral  load (log10)a 3.483 (0–4.500) NA
CD4 (%)a 31.3 (24.9–38.1)
Antiretroviral therapy
Age  of ART initiation (months)a 21 (11–36) NA
Duration of ART (months)a 100.8 (64.9–85.5) NA
NA, not applicable; ART, antiretroviral therapy.
a Median (interquartile range 25–75).
b Mann–Whitney U-test.
c n (%)
d Chi square test.
e BMI (body mass index).
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tatistical  analyses
ata were  analyzed using Epi info 6.04 (Centers for Diseases
ontrol  and Prevention, Atlanta, GA, USA) and STATA 10.0
Stata  Corporation, College Station, TX, USA) statistical soft-
are.
Differences  in the anthropometric characteristics, dietary
ntake  and biochemical parameters among the children were
ssessed  using Student’s t-test (for normal distributions) or
 Mann–Whitney U-test (for non-normal distributions). Chi-
quare  test and Fisher’s exact test were applied to assess
he  association between the categorical variables according to
re-established cut-off points. Pearson’s and Spearman’s tests
ere used to study the correlations between the dietary intake
nd  the biochemical parameters. The statistical signiﬁcance
evel  was  set at p-value <0.05.
esults
here were  83 prepubertal children who participated in
he  study, 51 were  HIV-infected children and 32 were HIV-
ninfected  children. Table 1 shows the anthropometric
haracteristics and the nutritional status of both groups and
lso  the virological and immunological parameters of HIV-
nfected  children. The groups were comparable in terms of
ender,  BMI  and proportion of individuals with normal weight.
he  median age of the HIV-infected group was  lower than that
f  the control group. The proportion of stunted individuals
smaller height-for-age z-score) was  higher in the HIV-infected
roup  than in the control group (p = 0.0006). No signiﬁcant cor-
elation  between zinc levels and short stature was  found.The macro- and micronutrient intakes are shown in Table 2.
There  was  higher percentage of subjects (45.1%) in the
HIV-infected group with dietary zinc intake below the EAR
(p  = 0.014) and no statistically signiﬁcant differences between
groups  with respect to macronutrients (g), selenium and cop-
per  consumption. HIV-infected group presented lower plasma
selenium  (p = 0.0006) and higher copper levels when compared
to  the control group (p = 0.019). Moreover, no difference was
found  concerning SOD activity or erythrocyte and serum zinc
levels  (Table 3). There were no signiﬁcant differences in the
concentration of trace elements according to different clinical
and  immunological categories of AIDS.
Discussion
Progression of HIV infection and adverse health effects of
antiretroviral medication lead to a chronic inﬂammatory con-
dition and to impaired immune system in the child. It is
therefore  crucial to evaluate and monitor the antioxidant
defense mechanisms that might inﬂuence the progression of
HIV  infection.20,21
In this study, the HIV-infected group had a higher propor-
tion  of stunting (11.8%) than the control group. Inadequate
growth in HIV-infected children can be directly caused by viral
infection  or indirectly by adverse environmental effects or by
a combination. The groups did neither differ in energy nor in
macronutrients intake.
Children  frequently consume monotonous diets character-
ized  by high intakes of simple carbohydrates, saturated and
trans-fats  (e.g., sugar, artiﬁcial juices, sweets, sausages and
fries).  Compared to the control group, the HIV-infected chil-
dren  had the highest proportion of subjects with zinc intakes
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Table 2 – Dietary assessment of energy, macronutrients and micronutrients of HIV-infected (n = 51) and control (n = 32)
groups.
Dietary assessment HIV-infected Control p value
TEa (Kcal) b,c 1892.18 (411.97) 2002.66 (460.13) 0.2591
EERb,d 1593 (172) 1788 (319)
Carbohydrates (g)b,c 250.44 (61.04) 261.01 (57.70) 0.4356
Proteins (g)b,c 66.78 (16.65) 69.42 (18.58) 0.5032
Total fats (g)b,c 69.12 (15.74) 75.63 (21.37) 0.1143
Selenium (g)b,c 51.15 (16.16) 49.08 (15.25) 0.5635
Selenium < EARe,f,g,h 5 (9.8) 4 (12.5) 0.4823
Zinc (mg)i , j 8.8 (7.4–10.7) 9.0 (7.4–10.7) 0.7013
Zinc < EARe,f,g,k 23 (45.1) 6 (18.8) 0.0140
Copper (mg)i , j 0.96 (0.84–1.18) 1.10 (0.84–1.18) 0.3212
Copper < EARe,f,g,h 3 (5.9) 2 (6.2) 0.6437
a TE (total energetic value).
b Mean (standard deviation).
c Student’s t-test.
d EER (estimated energy requirement).
e EAR (estimated average requirement).
f Altered values < EAR.
g n (%).
h Fisher’s exact test.
i Median (interquartile range 25–75).
j Mann–Whitney U-test.
k Chi square test.
Table 3 – Biochemical parameters of HIV-infected and control groups.
Biochemical parameter n HIV group n Control group p value
Plasma selenium (g/L)a,b 50 31.45 (8.91) 32 38.80 (9.49) 0.0006
Low < 2.5 percentilec,d,e 48 (96.0) 27.0 (84.4) 0.0780
Erythrocyte zinc (g/gHb)a,f 51 25.0 (7.9) 32 25.0 (10.14) 0.8223
Low (<40 g/gHb)d,e,g 48 (94.12) 30 (93.8) 0.644
Serum zinc (mg/dL)a,f 51 52.3 (26.5) 32 69.4 (42.4) 0.0830
Low < 65 mg/dL (M) < 60 mg/dL (F)d,h,i 33 (64.7) 16 (50.0) 0.185
Serum copper (g/dL)a,f 51 120.83 (48.93) 32 105.78 (37.73) 0.0190
High > 140 g/dL (M) > 155 g/dL (F)d,e,h 16 (31.4) 7 (21.9) 0.9200
SOD activity (U/mg Hb)f , j 51 6.0 (5.3–6.5) 31 6.0 (5.4–6.6) 0.5856
High (>5.7 U/mg Hb)d,i 30 (58.8) 28 (96.6) 0.8366
CRP (mg/dL)j ,k 48 0.01 (0.01–0.22) 29 0.05 (0.01–0.07) 0.5022
Low (<0.8 mg/dL)a,e 7 (14.6) 1 (3.4) 0.1194
F, female; M, male.
a Mean (standard deviation).
b Student’s t-test.
c Bates et al.15
d n (%).
e Fisher’s exact test.
f Mann–Whitney U-test.
g Guthrie and Picciano.18
h Gibson.17
i Chi square test.
j Median (interquartile range 25–75).
below the EAR; however no association with zinc biochemical
parameters was  found. This result can be explained by the low
consumption of protein that is rich in zinc.Lower selenium levels were  found in the HIV infected
group. These results suggest that the low plasma selenium
of  the HIV-infected group could be associated with increasedrequirement for antioxidants to neutralize oxidative stress.
Plasma  selenium level is a sensitive indicator of disease pro-
gression  and risk of mortality in HIV-infected children.4,22 It
maintains  a healthy immune system, acts as an antioxidant
and  might regulate viral expression.4 Selenium deﬁciency was
associated  with higher mortality risk regardless of the CD4+ T
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ell count4 and may  be related to protein-energy malnutrition
ommonly found in HIV-infected patients.1
A study found no selenium deﬁciency in healthy and HIV-
nfected  adolescents; however, immune function assessed by
lasma neopterin concentration was  negatively correlated
ith  plasma selenium levels.23 Poor selenium intakes and
alabsorption may  contribute to selenium deﬁciency, which
ffects  the immune system and the cardiac muscle of HIV-
nfected  subjects.1
The HIV-infected group had higher serum copper level.
oreno  et al. found higher serum copper concentrations in
IV-infected  subjects regardless of gender when compared to
he healthy controls. These results suggest that copper is an
cute  phase reactant and its serum concentration can be used
s  a surrogate marker for HIV progression, as well as in other
hronic  infections and inﬂammatory diseases.24 Serum cop-
er  levels are not good markers of the inﬂammatory response
ecause  the concentration of this micronutrient appears to
eﬂect interactions among different pathological processes.25
ecause of its participation in LDL-c oxidation within artery
alls,  under and overconsumption of copper can result in
therogenesis.26,27 However, copper is a constituent of SOD
nd  ceruloplasmin, which are involved in preventing oxidative
tress.26,27
The CRP level was  not signiﬁcantly different between the
roups;  therefore, it was  not possible to characterize the acute
nﬂammatory  process in the children. This result may  be
xplained  by the fact that, despite having moderate or severe
linical  and immunological categories, the children were not
ospitalized  or presented severe clinical complications in the
ear  prior to entering the study.
Our study had a small number of subjects in the
IV-infected and HIV-uninfected groups, which limits the
xtrapolation of our ﬁndings to other HIV-infected children.
owever, our HIV-infected and control populations were from
he same families; therefore they had similar food access.
HIV-infected children can be exposed to numerous risk fac-
ors  that impair their immune function, including inadequate
utritional status for trace elements, which could inﬂuence
he  progression of HIV infection. Assessing dietary intake and
iochemical  parameters are essential in the clinical practice
n  order to identify and treat early micronutrients deﬁciency
inimizing clinical and metabolic alterations.
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